Transgender and gender diverse individuals who were hospitalized for psychiatric care were less likely to have a follow-up visit compared to the general population, suggesting they face transphobia in the hospital system.
Novel antibodies show promise for tumor targeting and RAD51 inhibition
A new research paper was published in Oncotarget’s Volume 15 on October 1, 2024, entitled, “Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition.”
October 21, 2024